In two separate studies, Vora and colleagues employed similar methodologies, measuring the rate of absorption of 125I-labeled insulin actrapid from different injection sites in healthy participants (37) and those with T1D (38), with otherwise matched characteristics. This evidence concerns the gene INS and type 1 diabetes mellitus.